• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种膜活性药物(普萘洛尔、尼莫地平和胺碘酮)药代动力学和药效学的可能分子基础。

Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: propranolol, nimodipine and amiodarone.

作者信息

Herbette L G, Trumbore M, Chester D W, Katz A M

机构信息

Department of Medicine, University of Connecticut, Farmington 06032.

出版信息

J Mol Cell Cardiol. 1988 May;20(5):373-8. doi: 10.1016/s0022-2828(88)80128-7.

DOI:10.1016/s0022-2828(88)80128-7
PMID:3210248
Abstract

The interactions of propranolol, nimodipine, and amiodarone with membrane lipids were examined in an effort to explain their different pharmacokinetic and pharmacodynamic properties. Propranolol and nimodipine, which bind with high affinity to plasmalemmal beta-adrenergic and calcium channel receptors, respectively, have membrane partition coefficients of approximately 1200 and 5000 and are readily washed out of membranes with which they had been equilibrated. X-ray and neutron diffraction studies showed that after partitioning into lipid membranes, both propranolol and nimodipine are located approximately 6 A from the phosphate headgroup region of the membrane bilayer, near the hydrocarbon core/water interface. Amiodarone, which blocks Na and K channels with less site specificity than propranolol and nimodipine, has a much higher partition coefficient of approximately 1,000,000, resists washout from membrane bilayers, and is located deeper in the membrane, approximately 12 A from the phosphate headgroup region of the bilayer, nearer to the terminal methyl groups of the fatty acyl chains. The shorter durations of clinical action of propranolol and nimodipine may be related to the reversibility of their interactions with the region of the bilayer exposed to the aqueous media near the hydrocarbon core/water interface, whereas the much longer duration of clinical action of amiodarone may reflect a location more deeply within the fatty acyl region of the bilayer where this hydrophobic drug interacts avidly with the hydrocarbon core of the membrane.

摘要

为了解释普萘洛尔、尼莫地平和胺碘酮不同的药代动力学和药效学特性,对它们与膜脂的相互作用进行了研究。普萘洛尔和尼莫地平分别与质膜β-肾上腺素能受体和钙通道受体具有高亲和力结合,它们的膜分配系数分别约为1200和5000,并且很容易从与其平衡的膜中被洗脱。X射线和中子衍射研究表明,在分配到脂质膜中后,普萘洛尔和尼莫地平都位于距膜双层磷酸头部基团区域约6埃处,靠近烃核心/水界面。胺碘酮阻断钠和钾通道的位点特异性比普萘洛尔和尼莫地平低,其分配系数高得多,约为1,000,000,能抵抗从膜双层中被洗脱,并且位于膜中更深的位置,距双层磷酸头部基团区域约12埃,更靠近脂肪酰链的末端甲基。普萘洛尔和尼莫地平临床作用持续时间较短可能与其与烃核心/水界面附近暴露于水性介质的双层区域相互作用的可逆性有关,而胺碘酮临床作用持续时间长得多可能反映其在双层脂肪酰区域内更深的位置,这种疏水药物在该位置与膜的烃核心强烈相互作用。

相似文献

1
Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: propranolol, nimodipine and amiodarone.三种膜活性药物(普萘洛尔、尼莫地平和胺碘酮)药代动力学和药效学的可能分子基础。
J Mol Cell Cardiol. 1988 May;20(5):373-8. doi: 10.1016/s0022-2828(88)80128-7.
2
Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism.非特异性位点相互作用机制抑制1,4 - 二氢吡啶类钙通道药物与其受体结合的分子基础。
Biophys J. 1992 May;61(5):1244-55. doi: 10.1016/S0006-3495(92)81933-1.
3
Comparisons of the interaction of propranolol and timolol with model and biological membrane systems.普萘洛尔和噻吗洛尔与模型及生物膜系统相互作用的比较。
Mol Pharmacol. 1983 Sep;24(2):259-69.
4
Comparison of location and binding for the positively charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes.带正电荷的1,4 - 二氢吡啶类钙通道拮抗剂氨氯地平与该类不带电荷药物在心肌膜中的定位和结合比较。
Mol Pharmacol. 1989 Oct;36(4):634-40.
5
Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors.1,4-二氢吡啶类钙通道拮抗剂与生物膜的相互作用:药物与受体结合之前可能发生脂质双分子层分配。
J Mol Cell Cardiol. 1989 Feb;21(2):187-201. doi: 10.1016/0022-2828(89)90861-4.
6
Partitioning and location of Bay K 8644, 1,4-dihydropyridine calcium channel agonist, in model and biological membranes.1,4 -二氢吡啶类钙通道激动剂Bay K 8644在模型膜和生物膜中的分配与定位
Biophys J. 1989 Apr;55(4):769-78. doi: 10.1016/S0006-3495(89)82875-9.
7
Structure and location of amiodarone in a membrane bilayer as determined by molecular mechanics and quantitative x-ray diffraction.通过分子力学和定量X射线衍射确定的胺碘酮在膜双分子层中的结构与位置。
Biophys J. 1988 Sep;54(3):535-43. doi: 10.1016/S0006-3495(88)82986-2.
8
The separate profile structures of the functional calcium pump protein and the phospholipid bilayer within isolated sarcoplasmic reticulum membranes determined by X-ray and neutron diffraction.通过X射线和中子衍射确定的分离的肌浆网细胞膜内功能性钙泵蛋白和磷脂双层的轮廓结构。
Biochim Biophys Acta. 1985 Jul 11;817(1):103-22. doi: 10.1016/0005-2736(85)90073-2.
9
Differential effects of amiodarone and propranolol on lipid dynamics and enzymatic activities in cardiac sarcolemmal membranes.胺碘酮和普萘洛尔对心肌肌膜脂质动力学及酶活性的不同影响。
Biochem Pharmacol. 1989 Apr 15;38(8):1231-9. doi: 10.1016/0006-2952(89)90328-6.
10
Interaction of amphiphilic molecules with biological membranes. A model for nonspecific and specific drug effects with membranes.两亲性分子与生物膜的相互作用。一种关于膜的非特异性和特异性药物作用的模型。
Adv Myocardiol. 1985;5:333-46.

引用本文的文献

1
Mechanistic studies on pH-permeability relationships: Impact of the membrane polar headgroup region on pKa.pH-渗透性关系的机制研究:膜极性头部基团区域对pKa的影响。
Int J Pharm. 2025 Mar 30;673:125383. doi: 10.1016/j.ijpharm.2025.125383. Epub 2025 Feb 22.
2
Effect of the Membrane Environment on Pharmacologic Inhibition of hERG K Channel Activity.膜环境对人乙醚-a- go-go相关基因(hERG)钾通道活性的药理学抑制作用
JACC Clin Electrophysiol. 2025 Apr;11(4):708-719. doi: 10.1016/j.jacep.2024.11.016. Epub 2025 Jan 29.
3
Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants.
耳挛缩综合征 2 是由 PLCB4 变异体的显性负作用引起的。
Dis Model Mech. 2022 Apr 1;15(4). doi: 10.1242/dmm.049320. Epub 2022 Apr 29.
4
Cerebral Autoregulation in Subarachnoid Hemorrhage.蛛网膜下腔出血中的脑自动调节
Front Neurol. 2021 Jul 23;12:688362. doi: 10.3389/fneur.2021.688362. eCollection 2021.
5
Nimodipine Pharmacokinetic Variability in Various Patient Populations.尼莫地平在不同患者人群中的药代动力学变异性。
Drugs R D. 2020 Dec;20(4):307-318. doi: 10.1007/s40268-020-00322-3.
6
Dynamic Protonation Dramatically Affects the Membrane Permeability of Drug-like Molecules.动态质子化极大地影响类药性分子的膜通透性。
J Am Chem Soc. 2019 Aug 28;141(34):13421-13433. doi: 10.1021/jacs.9b04387. Epub 2019 Aug 16.
7
Morphological Effects Induced In Vitro by Propranolol on Human Erythrocytes.普萘洛尔对人红细胞的体外形态学影响
J Membr Biol. 2015 Aug;248(4):683-93. doi: 10.1007/s00232-015-9780-2. Epub 2015 Feb 28.
8
Lipid raft involvement in yeast cell growth and death.脂筏参与酵母细胞的生长和死亡。
Front Oncol. 2012 Oct 10;2:140. doi: 10.3389/fonc.2012.00140. eCollection 2012.
9
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.作为延长体内药物作用的机制,长效的靶标结合和再结合。
Br J Pharmacol. 2010 Oct;161(3):488-508. doi: 10.1111/j.1476-5381.2010.00936.x.
10
Ligands, their receptors and ... plasma membranes.配体、它们的受体和……质膜。
Mol Cell Endocrinol. 2009 Nov 13;311(1-2):1-10. doi: 10.1016/j.mce.2009.07.022. Epub 2009 Jul 30.